ResultsIQ

ResultsIQ › Latest results › Sukhjit Starch & Chemicals Limited

Sukhjit Starch & Chemicals Limited Q1 FY26 earnings call summary

NSE: SUKHJITS · BSE: 524542

Earnings call of 13 Aug 2025, summarised by AI from the filing.

Sukhjit Starch Q1 FY26 revenue ₹367.20 cr, EBITDA ₹19.89 cr with 5.42% margin, net profit ₹4.75 cr; targeting 80%-85% utilisation this fiscal.

Key takeaways

  1. Utilisation guidance Targeting 80%-85% utilisation for this fiscal; running at 85%.
  2. Margin driver Raw material price correction and price stabilisation improved margins; no inventory loss booked.
  3. Demand Stable pricing and rising offtake across food processing, textiles, paper and pharmaceuticals.

Original filing on BSE

Sukhjit Starch & Chemicals Limited Q1 FY27 results

As filed: Revenue ₹396 cr (+7% year on year), EBITDA ₹30.2 cr (+59% year on year), PAT ₹12.2 cr (+143% year on year), EBITDA margin 7.6% (+247 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹402 cr (+12% year on year), EBITDA ₹25.8 cr (+52% year on year), PAT ₹14.6 cr (+300% year on year), EBITDA margin 6.4% (+171 bps). Score 85 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 171 bps year on year. Other income 44% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −12.6% in 29 days (Nifty 500: +0.9%).
  • Q3 FY26: Revenue ₹347 cr (−7% year on year), EBITDA ₹19.5 cr (−33% year on year), PAT ₹3.1 cr (−72% year on year), EBITDA margin 5.6% (−211 bps). Score 19 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 211 bps year on year. Other income 41% of PBT. Profit fell 22% from last quarter. Share price after the results: −8.9% in 29 days (Nifty 500: −10.1%).
  • Q2 FY26: Revenue ₹315 cr (−14% year on year), EBITDA ₹18.0 cr (−44% year on year), PAT ₹4.0 cr (−69% year on year), EBITDA margin 5.7% (−298 bps). Score 5 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 298 bps year on year. Other income 100% of PBT. Tax rate 0%. Revenue fell 15% from last quarter. Share price after the results: −4.0% in 29 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹369 cr (−7% year on year), EBITDA ₹19.0 cr (−42% year on year), PAT ₹5.0 cr (−64% year on year), EBITDA margin 5.2% (−321 bps). Score 12 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 321 bps year on year. Other income 50% of PBT. Share price after the results: +2.7% in 30 days (Nifty 500: +2.1%).
  • Q4 FY25: Revenue ₹360 cr (−3% year on year), EBITDA ₹17.0 cr (−48% year on year), PAT ₹3.0 cr (−75% year on year), EBITDA margin 4.7% (−420 bps). Score 3 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 420 bps year on year. Other income 75% of PBT. Tax rate 50%. Revenue fell 4% from last quarter. Share price after the results: −13.3% in 28 days (Nifty 500: +3.3%).
  • Q3 FY25: Revenue ₹375 cr (+4% year on year), EBITDA ₹29.0 cr (−19% year on year), PAT ₹11.0 cr (−31% year on year), EBITDA margin 7.7% (−224 bps). Score 29 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 224 bps year on year. Profit fell 15% from last quarter.
  • Q2 FY25: Revenue ₹368 cr (+15% year on year), EBITDA ₹32.0 cr (+7% year on year), PAT ₹13.0 cr (+18% year on year), EBITDA margin 8.7% (−65 bps). Score 63 of 100, In line with trend. Revenue, EBITDA and profit growth were above the company's own trend. EBITDA margin fell 65 bps year on year. Revenue fell 7% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Sukhjit Starch & Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.